» Articles » PMID: 19846871

The Natural Cytotoxicity Receptor NKp46 is Dispensable for IL-22-mediated Innate Intestinal Immune Defense Against Citrobacter Rodentium

Overview
Journal J Immunol
Date 2009 Oct 23
PMID 19846871
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Natural cytotoxicity receptors (including NKp30, NKp44, and NKp46 in humans and NKp46 in mice) are type I transmembrane proteins that signal NK cell activation via ITAM-containing adapter proteins in response to stress- and pathogen-induced ligands. Although murine NKp46 expression (encoded by Ncr1) was thought to be predominantly restricted to NK cells, the identification of distinct intestinal NKp46(+) cell subsets that express the transcription factor Rorc and produce IL-22 suggests a broader function for NKp46 that could involve intestinal homeostasis and immune defense. Using mice carrying a GFP-modified Ncr1 allele, we found normal numbers of gut CD3(-)GFP(+) cells with a similar cell surface phenotype and subset distribution in the absence of Ncr1. Splenic and intestinal CD3(-)NKp46(+) cell subsets showed distinct patterns of cytokine secretion (IFN-gamma, IL-22) following activation via NK1.1, NKp46, IL-12 plus IL-18, or IL-23. However, IL-22 production was sharply restricted to intestinal CD3(-)GFP(+) cells with the CD127(+)NK1.1(-) phenotype and could be induced in an Ncr1-independent fashion. Because NKp46 ligands can trigger immune activation in the context of infectious pathogens, we assessed the response of wild-type and Ncr-1-deficient Rag2(-/-) mice to the enteric pathogen Citrobacter rodentium. No differences in the survival or clinical score were observed in C. rodentium-infected Rag2(-/-) mice lacking Ncr1, indicating that NKp46 plays a redundant role in the differentiation of intestinal IL-22(+) cells that mediate innate defense against this pathogen. Our results provide further evidence for functional heterogeneity in intestinal NKp46(+) cells that contrast with splenic NK cells.

Citing Articles

Natural Killer-Based Therapy: A Prospective Thought for Cancer Treatment Related to Diversified Drug Delivery Pathways.

Zang J, Mei Y, Zhu S, Yin S, Feng N, Ci T Pharmaceutics. 2024; 16(7).

PMID: 39065636 PMC: 11279587. DOI: 10.3390/pharmaceutics16070939.


Antibody Fc-receptor FcεR1γ stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity.

Huang C, Zhu W, Li Q, Lei Y, Chen X, Liu S Nat Commun. 2024; 15(1):5981.

PMID: 39013884 PMC: 11252441. DOI: 10.1038/s41467-024-50266-4.


NK cell-activating receptor NKp46 does not participate in the development of obesity-induced inflammation and insulin resistance.

Nathalie G, Bonamichi B, Kim J, Jeong J, Kang H, Hartland E Mol Cells. 2024; 47(3):100007.

PMID: 38238205 PMC: 11004397. DOI: 10.1016/j.mocell.2023.100007.


Preventive Effect of Vitamin C on Dextran Sulfate Sodium (DSS)-Induced Colitis via the Regulation of IL-22 and IL-6 Production in Gulo(-/-) Mice.

Jo H, Lee D, Go C, Jang Y, Chu N, Bae S Int J Mol Sci. 2022; 23(18).

PMID: 36142515 PMC: 9505994. DOI: 10.3390/ijms231810612.


Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut.

Zhou W, Sonnenberg G Trends Immunol. 2020; 41(8):721-733.

PMID: 32646594 PMC: 7395873. DOI: 10.1016/j.it.2020.06.009.